Venous thromboembolism (VTE) occurs in 2.1 to up to 50% of children with cancer and
contributes to long term morbidity as well as early mortality in this population. Pediatric …

Pediatric cancer patients hold an increased risk of venous thromboembolism (VTE) due to
their cancer. Central venous catheters (CVCs) further increase the VTE risk. This systematic …

There are conflicting data about whether the development of cancer‐associated thrombo‐
embolism (TE) negatively impacts survival in children. The objective was to determine …

Objective To evaluate the accuracy of diagnostic algorithms developed using the
International Classification of Diseases (ICD-9-CM and ICD-10-CA) diagnostic codes and …

Thromboembolism (TE) is associated with reduced survival in pediatric acute lymphoblastic
leukemia (ALL). It has been hypothesized that TE might signal leukemic aggressiveness …

Acute venous thromboembolisms (VTEs) are serious complications that occur during acute
lymphoblastic leukemia (ALL) chemotherapy. The data elucidating risk factors for …

Methods: We performed a single-center, retrospective review of children 0 to 20 years of age
from 2012 to 2020 with malignancy and confirmed VTE, with the objective to evaluate the …

Thromboembolism (TE) is a major cause of morbidity and mortality in adult cancer patients;
however, there is a lack of sufficient knowledge on TE in pediatric cancer patients. We aimed …

Central venous catheter (CVC) dysfunction is often associated with thrombosis, which in turn
has been linked with poorer survival outcomes in cancer patients. Our objective was to …

Background: Thromboembolism is a well-recognized complication in children with cancer
and associated with chronic morbidity, delay of treatment, adverse events associated with …